Boston Scientific Corporation plans to acquire Axonics, Inc. for $3.7 billion in cash to expand its urology offerings with Axonics' innovative urinary and bowel disorder treatments. Axonics, founded ...
Original Image Link
Source:seekingalpha.com
Original Image Link
Source:seekingalpha.com
Posted: 2024-11-05 11:42:00